Literature DB >> 16007200

Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer.

Takayuki Fukui1, Masashi Kondo, Genshi Ito, Osamu Maeda, Naohito Sato, Hiromu Yoshioka, Kohei Yokoi, Yuichi Ueda, Kaoru Shimokata, Yoshitaka Sekido.   

Abstract

Secreted frizzled related protein 1 (SFRP 1) is an antagonist of the transmembrane frizzled receptor, a component of the Wnt signaling pathway, and has been suggested to be a candidate tumor suppressor in several human malignancies. Since SFRP 1 is located at chromosome 8 p 11, where lung cancers also exhibit frequent allelic loss, we hypothesized that the inactivation of SFRP 1 is also involved in lung carcinogenesis. To substantiate this, we performed mutational analysis of SFRP 1 for 29 non-small-cell lung cancer (NSCLC) and 25 small-cell lung cancer (SCLC) cell lines, and expression analysis for the same cell lines. Although somatic mutations were not detected in the coding sequence, downregulation of SFRP 1 was observed in 14 (48%) NSCLC and nine (36%) SCLC cell lines. We analysed epigenetic alteration of the SFRP 1 promoter region and detected hypermethylation in 15 (52%) of 29 NSCLC cell lines, two (8%) of 25 SCLC cell lines, and 44 (55%) of 80 primary lung tumors. By comparing the methylation status with SFRP 1 expression, we found a significant correlation between them. We also performed loss of heterozygosity (LOH) analysis and found that 15 (38%) of 40 informative surgical specimens had LOH in the SFRP 1 gene locus. Furthermore, we performed colony formation assay of two NSCLC cell lines (NCI-H 460 and NCI-H 2009) and found the reduction of colony formation with SFRP 1 transfection. In addition, we also detected that SFRP 1 inhibits the transcriptional activity of beta-catenin, which is thought to be a downstream molecule of SFRP 1, with luciferase reporter assay. Our current studies demonstrated that the SFRP 1 gene is frequently downregulated by promoter hypermethylation and suppresses tumor growth activity of lung cancer cells, which suggests that SFRP 1 is a candidate tumor suppressor gene for lung cancer. Oncogene (2005) 24, 6323-6327.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007200     DOI: 10.1038/sj.onc.1208777

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  70 in total

1.  Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.

Authors:  Wenyan Lu; Chia-Chen Liu; Jaideep V Thottassery; Guojun Bu; Yonghe Li
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

Review 2.  Development of anticancer agents targeting the Wnt/β-catenin signaling.

Authors:  Xiangqian Zhang; Jijun Hao
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

3.  High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor.

Authors:  Hekmat Osman Abdel-Aziz; Ichiro Takasaki; Yoshiaki Tabuchi; Kazuhiro Nomoto; Yoshihiro Murai; Koichi Tsuneyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2006-09-15       Impact factor: 4.553

4.  Regulation of SFRP-1 expression in the rat dental follicle.

Authors:  Dawen Liu; Shaomian Yao; Gary E Wise
Journal:  Connect Tissue Res       Date:  2012-03-14       Impact factor: 3.417

5.  Wnt antagonist gene polymorphisms and renal cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koichi Nakajima; Nobuyuki Kikuno; Soichiro Yamamura; Kazumori Kawakami; Yutaka Suehiro; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

Review 6.  Targeting Wnt pathways in disease.

Authors:  Zachary F Zimmerman; Randall T Moon; Andy J Chien
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

Review 7.  A Wnt survival guide: from flies to human disease.

Authors:  Andy J Chien; William H Conrad; Randall T Moon
Journal:  J Invest Dermatol       Date:  2009-01-29       Impact factor: 8.551

Review 8.  The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion.

Authors:  Peter Neth; Christian Ries; Marisa Karow; Virginia Egea; Matthias Ilmer; Marianne Jochum
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

Review 9.  The way Wnt works: components and mechanism.

Authors:  Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee
Journal:  Growth Factors       Date:  2012-12-21       Impact factor: 2.511

10.  SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.

Authors:  Dongtao Yin; Yan Jia; Yuanzi Yu; Malcolm V Brock; James G Herman; Chao Han; Xiaomo Su; Yang Liu; Mingzhou Guo
Journal:  Discov Med       Date:  2012-07       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.